NCC-ssRMS2-C1

Description

Cell line name NCC-ssRMS2-C1
Accession CVCL_A0BR
Resource Identification Initiative To cite this cell line use: NCC-ssRMS2-C1 (RRID:CVCL_A0BR)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: ~41 hours (PubMed=34164773).
Omics: SNP array analysis.
Misspelling: NCC-ssRMS1-C2; Note=In Cellosaurus release 39.
Derived from site: In situ; Back; UBERON=UBERON_0001137.
Sequence variations
Mutation; HGNC; 7611; MYOD1; None_reported; -; Zygosity=- (PubMed=34164773).
Disease Spindle cell/sclerosing rhabdomyosarcoma (NCIt: C121654)
Rhabdomyosarcoma (ORDO: Orphanet_780)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 40Y
Category Cancer cell line
STR profile

Source(s): PubMed=34164773

Markers:

Publications
PubMed=34164773; DOI=10.1007/s13577-021-00569-1
Tsuchiya R., Yoshimatsu Y., Noguchi R., Sin Y., Ono T., Sei A., Takeshita F., Sugaya J., Nakatani F., Yoshida A., Ohtori S., Kawai A., Kondo T.
Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
Hum. Cell 34:1569-1578(2021)

Cross-references
Encyclopedic resources Wikidata; Q108821015